Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
Project Title: NHS National Framework Agreement for the supply of Eculizumab - 1 Feb 2024<br/>Offer reference number: CM/PHR/22/5693<br/>Period of framework: 1 February 2024 to 30 April 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.
| Supplier | Identifier | Award Value | Lots Won | Cross-References |
|---|---|---|---|---|
| Alexion Pharmaceuticals | - | ~£122,287,000 estimated from lot values | 1 lot Lot 1 | - |
| Amgen Ltd | 02354269 | ~£122,287,000 estimated from lot values | 1 lot Lot 1 | - |
| Samsung Bioepis UK Ltd | 08840722 | ~£122,287,000 estimated from lot values | 1 lot Lot 1 | - |
This procurement was divided into 1 lots, each awarded separately. 9 bids were received in total.
| Lot | Value | Bids Received | Awarded To | Status |
|---|---|---|---|---|
| Lot 1 Feb 2024 – Apr 2025 | £122,287,000 £3 initial term | 3 | Samsung Bioepis UK Ltd Alexion Pharmaceuticals Amgen Ltd | active |
Weightings from the notice.
Government spending data: These suppliers have received £8,180,106 in 819 payments (over £25k) from Guy's and St Thomas' NHS FT, University Hospitals Bristol and Weston NHS FT, Manchester University NHS Foundation Trust, Department of Health and Social Care, Maidstone and Tunbridge Wells NHS Trust and 7 more public bodies (2019-04-17 to 2026-03-26).
Published by the buyer on this notice. Check the original notice — details change and are not updated here.